Modest decrease in pgc1α results in TAG accumulation but not in insulin resistance in L6 myotubes

Cellular Physiology and Biochemistry

Volumn 35, Issue 4, 2015, Pages 1609-1622

  Lukaszuk, Bartlomiej ^a   Miklosz, Agnieszka ^a   Chabowski, Adrian ^a   Górski, Jan ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Insulin resistance; Lipids; Mitochondria; PGC 1 ; Skeletal muscle

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; CERAMIDE; CYTOCHROME C; DIACYLGLYCEROL; FATTY ACID; FATTY ACID TRANSPORTER; GLUCOSE; GLUCOSE TRANSPORTER; MITOCHONDRIAL ENZYME; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TRIACYLGLYCEROL; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; INSULIN; MITOCHONDRIAL PROTEIN; PPARGC1A PROTEIN, RAT; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FATTY ACID OXIDATION; GAS LIQUID CHROMATOGRAPHY; GENE EXPRESSION; GENE SILENCING; GLUCOSE TRANSPORT; INSULIN RESISTANCE; ISOTOPE LABELING; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; MITOCHONDRIAL RESPIRATION; MYOTUBE; NONHUMAN; NUTRIENT; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; GAS CHROMATOGRAPHY; GENETICS; METABOLISM; MITOCHONDRION; RNA INTERFERENCE;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CERAMIDES; CHROMATOGRAPHY, GAS; DIGLYCERIDES; FATTY ACIDS; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 4; INSULIN; INSULIN RESISTANCE; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; PALMITIC ACID; RATS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRIGLYCERIDES;

EID: 84926321394     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000373975     Document Type: Article

References (32)

1. Melmed S, Polonsky KS, Larsen PR, Kronenberg HM: Williams textbook of endocrinology. Elsevier, 2011.
2. Straczkowski M, Kowalska I, Nikolajuk A, Dzienis-Straczkowska S, Kinalska I, Baranowski M, Zendzian-Piotrowska M, Brzezinska Z, Gorski J: Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle. Diabetes 2004;53:1215-1221.
3. Snel M, Jonker JT, Schoones J, Lamb H, de Roos A, Pijl H, Smit JW, Meinders AE, Jazet IM: Ectopic fat and insulin resistance: Pathophysiology and effect of diet and lifestyle interventions. Int J Endocrinol 2012;2012:983814.
4. Riserus U, Willett WC, Hu FB: Dietary fats and prevention of type 2 diabetes. Prog Lipid Res 2009;48:44-51.
5. Perry RJ, Samuel VT, Petersen KF, Shulman GI: The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature 2014;510:84-91.
6. DeFronzo RA, Tripathy D: Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 2009;32:S157-163.
7. Miklosz A, Lukaszuk B, Baranowski M, Gorski J, Chabowski A: Effects of inhibition of serine palmitoyltransferase (spt) and sphingosine kinase 1 (sphk1) on palmitate induced insulin resistance in l6 myotubes. PLoS One 2013;8:e85547.
8. Kiens B: Skeletal muscle lipid metabolism in exercise and insulin resistance. Physiol Rev 2006;86:205-243.
9. Timmers S, Schrauwen P, de Vogel J: Muscular diacylglycerol metabolism and insulin resistance. Physiol Behav 2008;94:242-251.
10. Summers SA: Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 2006;45:42-72.
11. Arany Z: Pgc-1 coactivators and skeletal muscle adaptations in health and disease. Curr Opin Genet Dev 2008;18:426-434.
12. Lin J, Handschin C, Spiegelman BM: Metabolic control through the pgc-1 family of transcription coactivators. Cell Metab 2005;1:361-370.
13. Finck BN, Kelly DP: Pgc-1 coactivators: Inducible regulators of energy metabolism in health and disease. J Clin Invest 2006;116:615-622.
14. Wright DC, Han DH, Garcia-Roves PM, Geiger PC, Jones TE, Holloszy JO: Exercise-induced mitochondrial biogenesis begins before the increase in muscle pgc-1alpha expression. J Biol Chem 2007;282:194-199.
15. Summermatter S, Baum O, Santos G, Hoppeler H, Handschin C: Peroxisome proliferator-activated receptor {gamma} coactivator 1{alpha} (pgc-1{alpha}) promotes skeletal muscle lipid refueling in vivo by activating de novo lipogenesis and the pentose phosphate pathway. J Biol Chem 2010;285:32793-32800.
16. Leick L, Fentz J, Bienso RS, Knudsen JG, Jeppesen J, Kiens B, Wojtaszewski JF, Pilegaard H: Pgc-1{alpha} is required for aicar-induced expression of glut4 and mitochondrial proteins in mouse skeletal muscle. Am J Physiol Endocrinol Metab 2010;299:E456-465.
17. Benton CR, Wright DC, Bonen A: Pgc-1alpha-mediated regulation of gene expression and metabolism: Implications for nutrition and exercise prescriptions. Appl Physiol Nutr Metab 2008;33:843-862.
18. Bonen A, Chabowski A, Luiken JJ, Glatz JF: Is membrane transport of ffa mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: Molecular, biochemical, and physiological evidence. Physiology (Bethesda) 2007;22:15-29.
19. Seyoum B, Fite A, Abou-Samra AB: Effects of 3t3 adipocytes on interleukin-6 expression and insulin signaling in l6 skeletal muscle cells. Biochem Biophys Res Commun 2011;410:13-18.
20. Constantinescu S, Turcotte LP: Genetic downregulation of receptor-interacting protein 140 uncovers the central role of akt signalling in the regulation of fatty acid oxidation in skeletal muscle cells. Exp Physiol 2013;98:514-525.
21. Miklosz A, Chabowski A, Zendzian-Piotrowska M, Gorski J: Effects of hyperthyroidism on lipid content and composition in oxidative and glycolytic muscles in rats. J Physiol Pharmacol 2012;63:403-410.
22. Chavez JA, Summers SA: Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3t3-l1 adipocytes and c2c12 myotubes. Arch Biochem Biophys 2003;419:101-109.
23. Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-917.
24. Yano M, Kishida E, Muneyuki Y, Masuzawa Y: Quantitative analysis of ceramide molecular species by high performance liquid chromatography. J Lipid Res 1998;39:2091-2098.
25. van Loon LJ, Goodpaster BH: Increased intramuscular lipid storage in the insulin-resistant and endurance-trained state. Pflugers Arch 2006;451:606-616.
26. Espinoza DO, Boros LG, Crunkhorn S, Gami H, Patti ME: Dual modulation of both lipid oxidation and synthesis by peroxisome proliferator-activated receptor-gamma coactivator-1alpha and-1beta in cultured myotubes. Faseb j 2010;24:1003-1014.
27. Ritov VB, Menshikova EV, Azuma K, Wood R, Toledo FG, Goodpaster BH, Ruderman NB, Kelley DE: Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity. Am J Physiol Endocrinol Metab 2010;298:E49-58.
28. Winder WW, Hardie DG: Amp-activated protein kinase, a metabolic master switch: Possible roles in type 2 diabetes. Am J Physiol 1999;277:E1-10.
29. Liang H, Balas B, Tantiwong P, Dube J, Goodpaster BH, O'Doherty RM, DeFronzo RA, Richardson A, Musi N, Ward WF: Whole body overexpression of pgc-1alpha has opposite effects on hepatic and muscle insulin sensitivity. Am J Physiol Endocrinol Metab 2009;296:E945-954.
30. Summermatter S, Shui G, Maag D, Santos G, Wenk MR, Handschin C: Pgc-1alpha improves glucose homeostasis in skeletal muscle in an activity-dependent manner. Diabetes 2013;62:85-95.
31. Lee WJ, Kim M, Park HS, Kim HS, Jeon MJ, Oh KS, Koh EH, Won JC, Kim MS, Oh GT, Yoon M, Lee KU, Park JY: Ampk activation increases fatty acid oxidation in skeletal muscle by activating pparalpha and pgc-1. Biochem Biophys Res Commun 2006;340:291-295.
32. Benton CR, Holloway GP, Han XX, Yoshida Y, Snook LA, Lally J, Glatz JF, Luiken JJ, Chabowski A, Bonen A: Increased levels of peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (pgc-1alpha) improve lipid utilisation, insulin signalling and glucose transport in skeletal muscle of lean and insulin-resistant obese zucker rats. Diabetologia 2010;53:2008-2019.